This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. This issue profiles novel antibody dependent cellular cytotoxicity enhancement technology, an efficient mammalian cell culture technology platform for protein production, and an algae-based purification platform for mammalian cell harvesting.

    $250.00
  2. This issue profiles real-time immune system imaging that helps in efficient disease management, a quantitative analysis tool for disease detection, and coronary stents for embolic protection.

    $950.00
  3. This issue profiles genetic test patented for effective weight management, gene therapy for muscular dystrophy, and next generation sequencing tests for colorectal cancer.

    $250.00
  4. This issue profiles a minimally-invasive procedure for excision of breast tissue, gas-sensing capsules to track intestinal gases, and an automated fundus camera to screen patients for eye disorders.

    $950.00
  5. This issue profiles personalized treatment for prostate cancer patients, personal genomics that paves the way for future medicine and health, and gene therapy for ophthalmic diseases.

    $250.00
  6. This issue profiles a novel drug to treat bile acid synthesis disorders, FDA approval for a drug for treatment of thyroid cancer, and a drug screening technology platform based on modulation of integrin activity.

    $950.00
  7. This issue profiles an innovative cell-free DNA blood test to detect Down syndrome, a novel experimental vaccine for Ebola, and a novel antibody therapy to reduce HIV loads.

    $250.00
  8. This issue profiles a nanoparticle-based wound therapy, a cancer drug found to be effective in treating arterio-venous malformations, and a gene responsible for insulin resistance.

    $250.00
  9. This issue profiles an imaging solution for early phase trials, a vendor neutral breast density analytic tool, and nanoparticles for multimodality use.

    $1,500.00
  10. This issue profiles nanotechnology for enhancing drug delivery, building biological optoelectronic probes with CNT transistors, and creating energy storage devices with graphene and nanotube carpets.

    $250.00